Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

373
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
373
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-specific oxidative stress and protective interventions in malathion-induced toxicity in rodent models: A comprehensive review.

Ecotoxicology and environmental safety·2026
Same author

RBFNN-Based PPy/GaN sensor array with wide dynamic range and sub-ppb detection for accurate ammonia identification in human exhaled breath.

Microsystems & nanoengineering·2025
Same author

Systematic Review and Meta-Analysis on Heavy Metals and Trace Elements in Mild Cognitive Impairment.

Biological trace element research·2025
Same author

Real-World Comparative Study of Ultra-Low-Dose Rivaroxaban in Very Elderly Patients with Atrial Fibrillation.

Clinical interventions in aging·2025
Same author

A Hierarchical PSMC-LQR Control Framework for Accurate Quadrotor Trajectory Tracking.

Sensors (Basel, Switzerland)·2025
Same author

Oxygen-Regulated GaN-Based Sensors Fabricated by MOCVD for Switchable Gas Detection: Exhaled Gas Smart Platform for Non-Invasive Disease Detection.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.8K

From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Lu Zhang1, Jianjun Tan1, Dan Han1

  • 1College of Life Science and Bio-engineering, Beijing University of Technology, Beijing, 100124, China.

Drug Discovery Today
|September 8, 2017
PubMed
Summary
This summary is machine-generated.

Machine intelligence, including machine learning and deep learning, accelerates rational drug discovery. These computational methods efficiently identify potential drug molecules from vast datasets, guiding early-stage drug design.

Related Experiment Videos

Last Updated: Feb 23, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.8K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Drug discovery

Background:

  • Traditional drug discovery experiments are time-consuming and expensive.
  • Machine intelligence has been historically applied to guide drug discovery processes.
  • The advent of 'big' data necessitates more powerful analytical tools.

Purpose of the Study:

  • To summarize the historical application of machine intelligence in rational drug discovery.
  • To provide insights into recent advancements in deep learning for drug discovery.
  • To highlight the role of evolving machine intelligence in modern drug design.

Main Methods:

  • Review of machine learning techniques, including quantitative structure-activity relationship (QSAR) modeling.
  • Analysis of deep learning approaches for handling large-scale datasets in drug discovery.
  • Historical perspective on the evolution of machine intelligence in the field.

Main Results:

  • Machine learning tools like QSAR modeling enable rapid and cost-effective identification of bioactive molecules.
  • Deep learning approaches offer enhanced power and efficiency for analyzing massive drug discovery data.
  • The evolution from machine learning to deep learning represents a significant advancement in computational drug design.

Conclusions:

  • Machine intelligence, particularly deep learning, is crucial for navigating the complexities of big data in drug discovery.
  • The progression of machine intelligence provides a robust framework for early-stage drug design and discovery.
  • Computational approaches are transforming rational drug discovery, making it faster and more efficient.